Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 4565630, 9 pages
https://doi.org/10.1155/2018/4565630
Research Article

Remote Ischemic Postconditioning Protects against Myocardial Ischemia-Reperfusion Injury by Inhibition of the RAGE-HMGB1 Pathway

1Department of Gerontology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
2Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
3Department of Cardiology, Jiangsu Shengze Hospital, Suzhou, China

Correspondence should be addressed to Zhijian Yang; nc.ude.umjn@jngnaynaijihz and Yan Guo; moc.liamtoh@15nayoug

Received 12 June 2017; Revised 23 November 2017; Accepted 24 December 2017; Published 23 January 2018

Academic Editor: Yukio Hayashi

Copyright © 2018 Xiangming Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. C. Becker and G. Ambrosio, “Myocardial consequences of reperfusion,” Progress in Cardiovascular Diseases, vol. 30, no. 1, pp. 23–44, 1987. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Matsumura, R. W. Jeremy, J. Schaper, and L. C. Becker, “Progression of myocardial necrosis during reperfusion of ischemic myocardium,” Circulation, vol. 97, no. 8, pp. 795–804, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. C. E. Murry, R. B. Jennings, and K. A. Reimer, “Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium,” Circulation, vol. 74, no. 5, pp. 1124–1136, 1986. View at Publisher · View at Google Scholar · View at Scopus
  4. Q. Chen, AK. Camara, J. An, and ML. Riess, “Cardiac preconditioning with 4-h, 17 degrees C ischemia reduces [Ca(2+)](i) load and damage in part via K(ATP) channel opening,” Am J Physiol Heart Circ Physiol, vol. 282, no. 6, pp. H196–H969, 2002. View at Google Scholar
  5. F. Roubille, A. Franck-Miclo, A. Covinhes et al., “Delayed postconditioning in the mouse heart in vivo,” Circulation, vol. 124, no. 12, pp. 1330–1336, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Xin, W. Zhu, J. Li et al., “Combined local ischemic postconditioning and remote perconditioning recapitulate cardioprotective effects of local ischemic preconditioning,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 298, no. 6, pp. H1819–H1831, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. P. Hoole, P. M. Heck, L. Sharples et al., “Cardiac remote ischemic preconditioning in coronary stenting (CRISP stent) study: a prospective, randomized control trial,” Circulation, vol. 119, no. 6, pp. 820–827, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Prunier, D. Angoulvant, C. Saint Etienne et al., “The RIPOST-MI study, assessing remote ischemic perconditioning alone or in combination with local ischemic postconditioning in ST-segment elevation myocardial infarction,” Basic Research in Cardiology, vol. 109, no. 2, article no. 400, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Liu, Y. Qu, R. Wang et al., “The alternative crosstalk between RAGE and nitrative thioredoxin inactivation during diabetic myocardial ischemia-reperfusion injury,” American Journal of Physiology-Endocrinology and Metabolism, vol. 303, no. 7, pp. E841–E852, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Kang, K. M. Livesey, H. J. Zeh, M. T. Lotze, and D. Tang, “Metabolic regulation by HMGB1-mediated autophagy and mitophagy,” Autophagy, vol. 7, no. 10, pp. 1256–1258, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Chen, S. Pang, N. Yang et al., “Beneficial effects of schisandrin B on the cardiac function in mice model of myocardial infarction,” PLoS ONE, vol. 8, no. 11, Article ID e79418, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. M. R. Schmidt, A. D. Sloth, J. Johnsen, and H. E. Bøtker, “Remote ischemic conditioning: the cardiologist's perspective,” Journal of Cardiovascular Medicine, vol. 13, no. 11, pp. 667–674, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. D. A. Liem, “Transient Limb Ischemia Induces Remote Ischemic Preconditioning In Vivo * Response,” Circulation, vol. 107, no. 24, pp. 218e–219, 2003. View at Publisher · View at Google Scholar
  14. F. Kerendi, H. Kin, M. E. Halkos et al., “Remote postconditioning: brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors,” Basic Research in Cardiology, vol. 100, no. 5, pp. 404–412, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Andreka, M. Vertesaljai, G. Szantho et al., “Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs,” Heart, vol. 93, no. 6, pp. 749–752, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Steffens, F. Montecucco, and F. Mach, “The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury,” Thrombosis and Haemostasis, vol. 102, no. 2, pp. 240–247, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Chandrasekar and G. L. Freeman, “Induction of nuclear factor κB and activation protein 1 in postischemic myocardium,” FEBS Letters, vol. 401, no. 1, pp. 30–34, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Li, Y. Gao, J. Tian, J. Shen, Y. Xing, and Z. Liu, “Sophocarpine administration preserves myocardial function from ischemia-reperfusion in rats via NF-κB inactivation,” Journal of Ethnopharmacology, vol. 135, no. 3, pp. 620–625, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. B. S. Cain, D. R. Meldrum, C. A. Dinarello et al., “Tumor necrosis factor-α and interleukin-1β synergistically depress human myocardial function,” Critical Care Medicine, vol. 27, no. 7, pp. 1309–1318, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Kimura, K. Shintani-Ishida, M. Nakajima, S. Liu, K. Matsumoto, and K.-I. Yoshida, “Ischemic preconditioning or p38 MAP kinase inhibition attenuates myocardial TNF α production and mitochondria damage in brief myocardial ischemia,” Life Sciences, vol. 78, no. 17, pp. 1901–1910, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Z. Kalea, A. M. Schmidt, and B. I. Hudson, “RAGE: a novel biological and genetic marker for vascular disease,” Clinical Science, vol. 116, no. 8, pp. 621–637, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Kislinger, C. Fu, B. Huber et al., “N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression,” The Journal of Biological Chemistry, vol. 274, no. 44, pp. 31740–31749, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. A. W. Opipari, H. M. Hu, R. Yabkowitz, and V. M. Dixit, “The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity,” The Journal of Biological Chemistry, vol. 267, pp. 12424–12427, 1992. View at Google Scholar
  24. D. M. Stern, S. D. Yan, S. F. Yan, and A. M. Schmidt, “Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes,” Ageing Research Reviews, vol. 1, no. 1, pp. 1–15, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Tanji, G. S. Markowitz, C. Fu et al., “Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease,” Journal of the American Society of Nephrology, vol. 11, no. 9, pp. 1656–1666, 2000. View at Google Scholar
  26. L. G. Bucciarelli, M. Kaneko, R. Ananthakrishnan et al., “Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury,” Circulation, vol. 113, no. 9, pp. 1226–1234, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Zeng, N. Feirt, M. Goldstein et al., “Blockade of Receptor for Advanced Glycation End Product (RAGE) Attenuates Ischemia and Reperfusion Injury to the Liver in Mice,” Hepatology, vol. 39, no. 2, pp. 422–432, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Muhammad, W. Barakat, S. Stoyanov et al., “The HMGB1 receptor RAGE mediates ischemic brain damage,” The Journal of Neuroscience, vol. 28, no. 46, pp. 12023–12031, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. M. Cohen, “Perspectives on RAGE signaling and its role in cardiovascular disease,” American Journal of Medical Genetics Part A, vol. 161, no. 11, pp. 2750–2755, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. J. H. Boyd, S. Mathur, Y. Wang, R. M. Bateman, and K. R. Walley, “Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-κB dependent inflammatory response,” Cardiovascular Research, vol. 72, no. 3, pp. 384–393, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. J. H. Boyd, B. Kan, H. Roberts, Y. Wang, and K. R. Walley, “S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products,” Circulation Research, vol. 102, no. 10, pp. 1239–1246, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Hu, B. Cui, X. Zhou, C. Xu, Z. Lu, and H. Jiang, “Ethyl pyruvate reduces myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats,” Molecular Biology Reports, vol. 39, no. 1, pp. 227–231, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Andrassy, H. C. Volz, J. C. Igwe et al., “High-mobility group box-1 in ischemia-reperfusion injury of the heart,” Circulation, vol. 117, no. 25, pp. 3216–3226, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. M. M. Mocanu, R. M. Bell, and D. M. Yellon, “PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning,” Journal of Molecular and Cellular Cardiology, vol. 34, no. 6, pp. 661–668, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Tong, K. Imahashi, C. Steenbergen, and E. Murphy, “Phosphorylation of glycogen synthase kinase-3β during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective,” Circulation Research, vol. 90, no. 4, pp. 377–379, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Krieg, Q. Qin, E. C. McIntosh, M. V. Cohen, and J. M. Downey, “ACh and adenosine activate PI3-kinase in rabbit hearts through transactivation of receptor tyrosine kinases,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 283, no. 6, pp. H2322–H2330, 2002. View at Publisher · View at Google Scholar
  37. D. J. Hausenloy, A. Tsang, M. M. Mocanu, and D. M. Yellon, “Ischemic preconditioning protects by activating prosurvival kinases at reperfusion,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 288, no. 2, pp. H971–H976, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Tsang, D. J. Hausenloy, M. M. Mocanu, and D. M. Yellon, “Postconditioning: a form of ‘modified reperfusion’ protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway,” Circulation Research, vol. 95, no. 3, pp. 230–232, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. C. J. Mullonkal and L. H. Toledo-Pereyra, “Akt in ischemia and reperfusion,” Journal of Investigative Surgery, vol. 20, no. 3, pp. 195–203, 2007. View at Publisher · View at Google Scholar · View at Scopus